Reimagining anti-inflammatory drugs delivery: the integration of ordered mesoporous silica and MOF materials for enhanced therapeutic outcomes
Source abstract
Abstract
Abstract Migraine, one of the neurological conditions, affects approximately 15% of the global population. It is characterized by intense headaches accompanied by nausea, vomiting, and heightened sensitivity to light. The first line of drugs for treating migraine are non-steroidal anti-inflammatory drugs. Unfortunately, these medications suffer from poor solubility in water, uncontrolled release, and numerous adverse side effects. In order to maximize their therapeutic effect by preventing premature release and degradation, novel drug delivery systems based on composites are being dynamically developed. Herein, the biocompatible ketoprofen (K), naproxen sodium (NS), and diclofenac sodium (DS) vehicles integrating ordered mesoporous silica (SBA-16) with Fe-based metal–organic frameworks (MIL-101(Fe)) were synthesized via the solvothermal method. The composites were characterized by different percentages of MIL-101(Fe) (25 and 50 wt.%), which had a significant impact on their porosity, structure, and number of functional groups. The SBA-16@MIL-101(Fe)-25 and SBA-16@MIL-101(Fe)-50 samples exhibited BET surface areas of 768 and 324 m2 g−1, respectively. Their sorption capacities towards selected anti-inflammatory drugs were in the range of 141–318 mg g−1 for K, 481–490 mg g−1 for NS, and 246–589 mg g−1 for DS, notably exceeding the values obtained for pure mesoporous silica (5–9 mg g−1). Morphological defects and specific functional groups, derived from SBA-16 and MIL-101(Fe), contributed to generating new adsorption sites in composites, enhancing host-guest interactions. The drug release profiles were determined by the carrier porosity, surface charge, and the presence of functional groups. The diffusion of K and DS from the composites into the phosphate buffer (pH 7.7), mimicking rectal fluid, occurred in a more controlled manner compared to pristine silica. The SBA-16@MIL-101(Fe)-50 carrier released 82% of K and 90% of DS over 24 h.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (95)
Show source-provided references
1. Drug delivery: an odyssey of 100 years10.1016/S1367-5931(00)00226-X ↗
2. From drug dosage forms to intelligent drug-delivery systems: a change of paradigm10.1039/9781849736800-00001 ↗
3. Cytoprotective activities of representative nutrients from the mediterranean diet and of mediterranean oils against 7-ketocholesterol- and 7β-hydroxycholesterol-Induced cytotoxicity: application to age-related diseases and civilization diseases10.1016/j.steroids.2022.109093 ↗
4. Global epidemiology of migraine and its implications for public health and health policy10.1038/s41582-022-00763-1 ↗
5. Diamine oxidase interactions with anti-inflammatory and anti-migraine medicines in the treatment of migraine10.3390/jcm12237502 ↗
6. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs10.1039/d0md00400f ↗
7. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment10.1016/j.mtbio.2022.100223 ↗
8. The bioavailability of drugs—the current state of knowledge10.3390/molecules28248038 ↗
9. Drug carriers: a review on the most used mathematical models for drug release10.3390/pr10061094 ↗
10. Applications of metal-organic frameworks as drug delivery systems10.3390/ijms23084458 ↗
11. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective10.1016/j.ebiom.2024.105301 ↗
12. Biomarker-driven molecular imaging probes in radiotherapy10.7150/thno.97768 ↗
13. MOF as nanoscale drug delivery devices: synthesis and recent progress in biomedical applications10.1016/j.jddst.2023.104285 ↗
14. Applications of reticular diversity in metal–organic frameworks: an ever-evolving state of the art10.1016/j.ccr.2020.213655 ↗
15. MIL-125-based nanocarrier decorated with palladium complex for targeted drug delivery10.1038/s41598-022-16058-w ↗
16. Mitigating metal-organic framework (MOF) toxicity for biomedical applications10.1016/j.cej.2023.144400 ↗
17. Nanoscale MOFs: from synthesis to drug delivery and theranostics applications10.1016/j.addr.2022.114496 ↗
18. Prospects, advances and biological applications of MOF-based platform for the treatment of lung cancer10.1039/d4bm00488d ↗
19. Fabrication of biocompatible magnetic maltose/MIL-88 metal–organic frameworks decorated with folic acid-chitosan for targeted and PH-responsive controlled release of doxorubicin10.1016/j.ijpharm.2023.122675 ↗
20. Biocompatible Fe-based metal-organic frameworks as diclofenac sodium delivery systems for migraine treatment10.3390/app132312960 ↗
21. Mesoporous silica-metal organic composite: synthesis, characterization, and ammonia adsorption10.1039/c1jm10451a ↗
22. Polymer-MOF hybrid composites with high porosity and stability through surface-selective ligand exchange10.1021/acs.chemmater.8b03881 ↗
23. Metal–organic framework composites for theragnostics and drug delivery applications10.1002/biot.202000005 ↗
24. Nanoporous metal organic frameworks as hybrid polymer–metal composites for drug delivery and biomedical applications10.1016/j.drudis.2016.10.001 ↗
25. Recent advances of ordered mesoporous silica materials for solid-phase extraction10.1016/j.chroma.2022.463157 ↗
26. Key parameters for the rational design, synthesis, and functionalization of biocompatible mesoporous silica nanoparticles10.3390/pharmaceutics14122703 ↗
27. Design and synthesis of ZnGlu MOF/SBA-16 nanocomposite, and its performance as an environmentally friendly nanocomposite for solvent-free chemical fixation of CO2 to epoxides for high-yield synthesis of cyclic carbonates10.1016/j.mcat.2023.113552 ↗
28. Loading and release study of ciprofloxacin from silica-coated magnetite modified by iron-based metal-organic framework (MOF) as a nonocarrier in targeted drug delivery system10.1016/j.inoche.2023.111056 ↗
29. Slow-release of curcumin induced by core–shell mesoporous silica nanoparticles (MSNs) modified MIL-100(Fe) composite10.1007/s10904-022-02230-2 ↗
30. hollow mesoporous silica@metal–organic framework and applications for ph-responsive drug delivery10.1002/cmdc.201800019 ↗
31. Synthesis of silica nanoparticles and their application of dielectric relaxation spectroscopy- a review10.1016/j.rechem.2023.101218 ↗
32. Immobilization of proteins in silica gel: biochemical and biophysical properties10.2174/1385272819666150601211349 ↗
33. Effect of methanol on the surface tension and viscosity of sodiumdodecyl sulfate (SDS) in aqueous medium at 298.15–323.15 K10.1016/j.kijoms.2017.10.004 ↗
34. Interfacial and micellization behavior of cetyltrimethylammonium bromide (CTAB) in water and methanol-water mixture at 298.15–323.15 K10.1155/2020/4653092 ↗
35. Investigation on the surface tension and viscosity of (dimethylsulfoxide + alcohol) mixtures by using gradient theory and eyring’s rate theory10.1007/s10765-020-02732-6 ↗
36. Modelling drug adsorption in metal-organic frameworks: the role of solvent10.1039/d1ra01746b ↗
37. Role of drug adsorption onto the silica surface in drug release from mesoporous silica systems10.1021/acs.molpharmaceut.7b00778 ↗
38. Single-pot hydrothermal derived TiO2/SBA-16 cubic mesoporous nanocomposite for humidity sensing10.1007/s10853-021-06822-0 ↗
39. Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate10.1016/j.jsps.2019.11.002 ↗
40. Compositing of MIL-101(Fe) with reduced graphene oxide and polyaniline for capacitive energy storage10.1016/j.matchemphys.2021.125641 ↗
41. The synthesis of Al-SBA-16 materials with a novel method and their catalytic application on hydrogenation for FCC diesel10.1021/acs.energyfuels.6b02095 ↗
42. An in situ synthesis of mesoporous SBA-16/hydroxyapatite for ciprofloxacin release: in vitro stability and cytocompatibility studies10.1007/s10856-014-5273-6 ↗
43. Adsorptive removal of tetracycline and ciprofloxacin drugs from water by using a magnetic Rod-like hydroxyapatite and MIL-101(Fe) metal-organic framework nanocomposite10.1039/d2ra06213e ↗
44. Efficient removal of toxic methylene blue (Mb) dye from aqueous solution using a metal-organic framework (Mof) Mil-101(Fe): isotherms, kinetics, and thermodynamic studies10.5004/dwt.2020.25599 ↗
45. Amino-functionalized MIL-101(Fe) metal-organic framework as a viable fluorescent probe for nitroaromatic compounds10.1007/s00604-017-2215-2 ↗
46. Synthesis and characterization of ordered mesoporous silica (SBA-15 and SBA-16) for adsorption of biomolecules10.1016/j.micromeso.2013.06.043 ↗
47. SBA-16 mesoporous nanosilica: synthesis, characterization and sorption properties10.46390/j.smensuen.23220.430 ↗
48. Synthesis, characterization and application of the SBA-16 catalyst modified with titanium(IV) chloride in the eugenol isomerization10.1016/j.micromeso.2020.110685 ↗
49. SBA-16 cage-like porous material modified with APTES as an adsorbent for Pb2+ ions removal from aqueous solution10.3390/ma13040927 ↗
50. Enhancement of aqueous stability of NH2-MIL-101(Fe) by hydrophobic grafting post-synthetic modification10.1007/s11356-021-14834-1 ↗
51. A plasmonic S-scheme Au/MIL-101(Fe)/BiOBr photocatalyst for efficient synchronous decontamination of Cr(VI) and norfloxacin antibiotic10.1016/j.esci.2023.100208 ↗
52. Exploration of the safety and solubilization, dissolution, analgesic effects of common basic excipients on the NSAID drug ketoprofen10.3390/pharmaceutics15020713 ↗
53. Hydrogels from xylan/chitosan complexes for the controlled release of diclofenac sodium10.1007/s10570-019-02850-x ↗
54. A novel approach for spectrophotometric determination of naproxen10.31838/ijpr/2020.SP2.162 ↗
55. Influence of dissolution conditions on the dissolution rate and release mechanism of ketoprofen from extended release hydrophilic matrix systems10.31925/farmacia.2022.2.20 ↗
56. Novel naproxen salts with increased skin permeability10.3390/pharmaceutics13122110 ↗
57. Adsorption of sodium diclofenac in aqueous medium using graphene oxide nanosheets10.1080/09593330.2019.1707882 ↗
58. Screening of new adsorbents to remove algal organic matter from aqueous solutions: kinetic analyses and reduction of disinfection by-products formation10.1007/s11356-022-22412-2 ↗
59. Preparation of GO/MIL-101(Fe,Cu) composite and its adsorption mechanisms for phosphate in aqueous solution10.1007/s11356-021-14206-9 ↗
60. A comprehensive review of anionic azo dyes adsorption on surface-functionalised silicas10.1007/s11356-022-23062-0 ↗
61. Adsorption and release properties of drug delivery system naproxen-SBA-15: effect of surface polarity, sodium/acid drug form and pH10.3390/jfb13040275 ↗
62. Optimization and characterization of silver nanoparticle-modified luffa for the adsorption of ketoprofen and reactive yellow 15 from aqueous solutions10.1038/s41598-024-54790-7 ↗
63. Biosorption of ketoprofen and diclofenac by living cells of the green microalgae chlorella Sp10.1007/s11356-021-15505-x ↗
64. Adsorption of pharmaceuticals and personal care products over metal-organic frameworks functionalized with hydroxyl groups: quantitative analyses of H-bonding in adsorption10.1016/j.cej.2017.04.036 ↗
65. Acid-promoted synthesis of MWCNT/UiO-66-NH2 nanocomposite for highly efficient removal of ketoprofen10.1246/cl.180953 ↗
66. Preparation of Poly(4-Vinylpyridine)-Functionalized Magnetic Al-MOF for the removal of naproxen from aqueous solution10.1016/j.jhazmat.2019.121144 ↗
67. Adsorptive removal of anti-inflammatory drugs from water using graphene oxide/metal-organic framework composites10.1016/j.cej.2017.10.138 ↗
68. Adsorption of naproxen and clofibric acid over a metal–organic framework MIL-101 functionalized with acidic and basic groups10.1016/j.cej.2013.01.002 ↗
69. Sulfonic-functionalized MIL-100-Fe MOF for the removal of diclofenac from water10.1016/j.micromeso.2022.112398 ↗
70. High adsorption of sodium diclofenac on post-synthetic modified zirconium-based metal-organic frameworks: experimental and theoretical studies10.1016/j.jcis.2021.08.158 ↗
71. The analyses of solvent effects on infrared spectra and thermodynamic parameters, hirshfeld surface, reduced density gradient and molecular docking of ketoprofen as a member of nonsteroidal anti-inflammatory drugs10.1016/j.molstruc.2021.131861 ↗
72. Physicochemical modeling of the adsorption of pharmaceuticals on MIL-100-Fe and MIL-101-Fe MOFs10.1155/2022/4482263 ↗
73. Thermosensitive drug delivery system SBA-15-PEI for Controlled release of nonsteroidal anti-inflammatory drug diclofenac sodium salt: a comparative study10.3390/ma14081880 ↗
74. Adsorptive removal of diclofenac sodium from aqueous solution via industrial processed citrus solid waste–based activated carbon: optimization, kinetics, equilibrium, thermodynamic, and reusability analyses10.1007/s13399-021-01969-x ↗
75. Monolayer and multilayer adsorption isotherm models for sorption from aqueous media10.1007/s11814-015-0053-7 ↗
76. Development of biocompatible iron-carboxylate metal organic frameworks for pH-responsive drug delivery application10.1166/jnn.2019.15402 ↗
77. Preparation of NiFe2O4@MIL-101(Fe)/GO as a novel nanocarrier and investigation of its antimicrobial properties10.1039/d1ra08523a ↗
78. Correlation between the transdermal permeation of ketoprofen and its solubility in mixtures of a pH 6.5 phosphate buffer and various solvents10.1080/107175402753413163 ↗
79. Study of physicochemical parameters affecting the release of diclofenac sodium from lipophilic matrix tablets
80. Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices10.1208/pt0802044 ↗
81. Bioavailability of naproxen sodium and its relationship to clinical analgesic effects10.1111/j.1365-2125.1980.tb01753.x ↗
82. pH-responsive mesoporous silica and carbon nanoparticles for drug delivery10.3390/bioengineering4010003 ↗
83. Ultra-small mesoporous silica nanoparticles as efficient carriers for pH responsive releases of anti-cancer drugs10.1039/c5dt03700j ↗
84. Controlled release of ketoprofen from electrospun poly(vinyl alcohol) nanofibers10.1016/j.msea.2007.01.039 ↗
85. Synthesis of magnetic coremesoporous silica shell nanoparticles using anionic surfactant and their application for ketoprofen control release10.1246/cl.2012.1357 ↗
86. Release pattern of three new polymers in ketoprofen controlled-release tablets10.5897/ajpp11.604 ↗
87. Zirconium metal organic framework/aloe vera carrier loaded with naproxen as a versatile platform for drug delivery10.1007/s11696-023-02719-1 ↗
88. Zn-based porous coordination solid as diclofenac sodium carrier10.1016/j.jssc.2018.01.011 ↗
89. Two biocompatible iron-based CPMs for high-capacity adsorption and pH-responsive sustained release of diclofenac sodium10.1039/d3ce01033c ↗
90. Enhancing antimicrobial activity of β-lactam antibiotic via functionalized mesoporous carbon-based delivery platforms10.1016/j.micromeso.2022.112160 ↗
91. Application of different mathematical models for further investigation of in vitro drug release mechanisms based on magnetic nano-composite10.1007/s00289-021-03537-9 ↗
92. Modelling of controlled drug release in gastrointestinal tract simulation10.1088/1742-6596/1295/1/012063 ↗
93. Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system10.1016/j.ejps.2017.12.012 ↗
94. Models for drug release of gentamicin in a polylactic acid matrix10.2140/MEMOCS.2020.8.307 ↗
95. Vancomycin release kinetics from Mg–Ca silicate porous microspheres developed for controlled drug delivery10.1016/j.ceramint.2019.08.290 ↗